Form 4 for BCYC BICYCLE THERAPEUTICS PLC
Accepted 2026-04-06 18:30:10 ET · period of report 2026-04-02 · accession 0002119908-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-04-06 18:30 | 2026-04-02+ | BCYC | Perry Jennifer Scott | COO | S - Sale | $4.94 | -1,408 | 92.5K | -1% | -$6,962 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-04-02 | S | D | 1,038 | $4.91 | 92,834 | D | — | — | (F1) Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.88 to $4.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4). |
| 2 | Common | Ordinary Shares | 2026-04-06 | S | D | 37 | $5.05 | 92,797 | D | — | — | (F1) Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. |
| 3 | Common | Ordinary Shares | 2026-04-06 | S | D | 333 | $5.04 | 92,464 | D | — | — | (F3) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on March 27, 2025. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.035 to $5.04 inclusive. |